Arbutus Biopharma Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for Arbutus Biopharma.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

The average analyst rating for Arbutus Biopharma stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '25	Dec '25	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	2	2	2	2	2	2
Buy	1	1	1	1	1	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	3	3	3	3	2

Financial Forecast

Revenue This Year

181.40M

from 14.08M

1,188.06%

from 14.08M

Revenue Next Year

2.70M

from 181.40M

-98.51%

from 181.40M

EPS This Year

-0.16

from -0.17

EPS Next Year

-0.05

from -0.16

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	10.99M	39.02M	18.14M	6.17M	14.08M	181.40M	2.70M
Revenue Growth	58.92%	255.11%	-53.51%	-65.98%	128.21%	1,188.06%	-98.51%
EPS	-0.83	-0.46	-0.44	-0.38	-0.17	0.75	-0.09
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	6.10	-
No. Analysts	-	-	-	-	-	1	1

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	181.4M	2.7M
Avg	181.4M	2.7M
Low	181.4M	2.7M

Revenue Growth

Revenue Growth	2026	2027
High	1,188.1%	-98.5%
Avg	1,188.1%	-98.5%
Low	1,188.1%	-98.5%

EPS Forecast

EPS	2026	2027
High	-0.16	-0.05
Avg	-0.16	-0.05
Low	-0.16	-0.05

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.